JY
LIMNW

Jeff Yass’s Liminatus Pharma Warrants LIMNW Stock Holding History

Jeff Yass’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32K Buy
+17,562
New +$1.21K ﹤0.01% 13236
2026
Q1 		– Sell
-23,906
Closed -$837 – 14469
2025
Q4 		$837 Buy
+23,906
New +$2.41K ﹤0.01% 12153

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Jeff Yass's LIMNW Position: Q2 2026 in Review

Jeff Yass opened a new position in Liminatus Pharma Warrants (LIMNW) in Q2 2026: 17,562 shares worth $1.32K. The stake represents ﹤0.01% of the portfolio and ranks #13236 among its holdings. This is a return to the name: Jeff Yass previously reported a position in LIMNW as recently as Q4 2025.

Jeff Yass first reported a position in LIMNW in Q4 2025 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold LIMNW as of Q2 2026.

  • Jeff Yass held 17,562 shares of Liminatus Pharma Warrants worth $1.32K as of Q2 2026.
  • Liminatus Pharma Warrants was a new Jeff Yass position in Q2 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13236 holding.
  • Jeff Yass first reported a position in Liminatus Pharma Warrants in Q4 2025 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.